DeepMed Research

ABBVIE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 2013-01-01

Employees: -

Market Cap: $346B

Website: http://www.abbvie.com

Clinical Trials

Special Investigation in Patients With Crohn's Disease (All Patients Investigation)

Completed

Conditions: Crohn's Disease

First Posted Date: 2011-02-18

Last Posted Date: 2018-07-02

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 1716

Registration Number: NCT01298648

Locations: 🇯🇵
Site Reference ID/Investigator# 60547, Tokyo, Japan
🇯🇵
Site Reference ID/Investigator# 80224, Tokyo, Japan
🇯🇵
Site Reference ID/Investigator# 56009, Yamaguchi, Japan

and more 1128 locations

A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America

Completed

Conditions: Respiratory Syncytial Virus Infection

First Posted Date: 2011-02-16

Last Posted Date: 2014-10-01

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 464

Registration Number: NCT01297504

Locations: 🇨🇴
Site Reference ID/Investigator# 52723, Bogota, Colombia
🇲🇽
Site Reference ID/Investigator# 52084, Mexico City, DF, Mexico
🇨🇴
Site Reference ID/Investigator# 52726, Barranquilla, Colombia

and more 21 locations

Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)

Completed

Conditions: Genital Endometriosis

First Posted Date: 2011-02-11

Last Posted Date: 2013-07-22

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 391

Registration Number: NCT01294371

Locations: 🇷🇺
Site Reference ID/Investigator# 50545, Perm, Russian Federation
🇷🇺
Site Reference ID/Investigator# 50567, Moscow, Russian Federation
🇷🇺
Site Reference ID/Investigator# 51643, Chelyabinsk, Russian Federation

and more 25 locations

Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab

Completed

Conditions: Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis

First Posted Date: 2011-01-25

Last Posted Date: 2015-11-09

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 500

Registration Number: NCT01282372

Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice

Completed

Conditions: Anesthesia, General

First Posted Date: 2011-01-24

Last Posted Date: 2013-03-04

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 1122

Registration Number: NCT01282203

Locations: 🇰🇿
Site Reference ID/Investigator# 64462, Kyzylorda, Kazakhstan
🇰🇿
Site Reference ID/Investigator# 54704, Uralsk, Kazakhstan
🇰🇿
Site Reference ID/Investigator# 51851, Almaty, Kazakhstan

and more 9 locations

Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab

Completed

Conditions: Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis

First Posted Date: 2011-01-10

Last Posted Date: 2014-03-26

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 155

Registration Number: NCT01273519

Locations: 🇦🇹
Site Reference ID/Investigator# 52143, Innsbruck, Austria
🇦🇹
Site Reference ID/Investigator# 44911, Linz, Austria
🇦🇹
Site Reference ID/Investigator# 44914, Graz, Austria

and more 12 locations

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands

Completed

Conditions: Kidney Failure, Chronic

First Posted Date: 2011-01-10

Last Posted Date: 2013-01-18

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 60

Registration Number: NCT01273597

Locations: 🇭🇺
Site Reference ID/Investigator# 46588, Nyiregyhaza, Hungary
🇭🇺
Site Reference ID/Investigator# 46593, Budapest, Hungary
🇭🇺
Site Reference ID/Investigator# 46585, Budapest, Hungary

and more 8 locations

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Completed

Conditions: Secondary Hyperparathyroidism
Chronic Kidney Disease

First Posted Date: 2010-12-24

Last Posted Date: 2014-02-19

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 50

Registration Number: NCT01265992

Locations: 🇸🇪
Site Reference ID/Investigator# 45188, Orebro, Sweden
🇸🇪
Site Reference ID/Investigator# 41085, Linkoping, Sweden
🇸🇪
Site Reference ID/Investigator# 57782, Stockholm, Sweden

and more 7 locations

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

Phase 4

Completed

Conditions: Psoriasis

Interventions: Biological: Adalimumab

First Posted Date: 2010-12-23

Last Posted Date: 2013-03-11

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 150

Registration Number: NCT01265823

Locations: 🇲🇽
Site Reference ID/Investigator# 41062, Toluca de Lerdo, Mexico
🇲🇽
Site Reference ID/Investigator# 40662, Toluca de Lerdo, Mexico
🇲🇽
Site Reference ID/Investigator# 40963, Zapopan, Mexico

and more 5 locations

A Study of ABT-806 in Subjects With Advanced Solid Tumor Types

Phase 1

Completed

Conditions: Advanced Solid Tumors

Interventions: Drug: ABT-806

First Posted Date: 2010-12-07

Last Posted Date: 2017-11-21

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 49

Registration Number: NCT01255657

Locations: 🇺🇸
Site Reference ID/Investigator# 43422, Tacoma, Washington, United States
🇺🇸
Site Reference ID/Investigator# 54056, Baltimore, Maryland, United States
🇺🇸
Site Reference ID/Investigator# 41931, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy